BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201028
DTEND;VALUE=DATE:20201029
DTSTAMP:20260403T200400
CREATED:20201019T120940Z
LAST-MODIFIED:20201019T120940Z
UID:18393-1603843200-1603929599@www.medilinkmidlands.com
SUMMARY:Making Pharmaceuticals Digital Week: Medilink UK Session
DESCRIPTION:Medilink UK are delighted to be presenting during the Making Pharmaceuticals Digital Week\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOn Wednesday\, 28 October Dr. Nicola Wall and Dr. Richard Weaver will present a live webinar on behalf of Medilink UK:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWorking with your CRO: Creating perfect research partnerships in an imperfect research world\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDr. Nicola Wall \nAfortiori Development\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBridging The Gap Between Discovery and Development – DMPK Influence\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDr. Richard Weaver \nXenoGesis Ltd\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe webinar is free to attend and will start at 11.00 GMT (12.00 CET | 06.00 EST) \nYou can register to attend using the button below.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRegister for free here\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nView the Full Digital Week Programme Here
URL:https://www.medilinkmidlands.com/event/making-pharmaceuticals-digital-week-medilink-uk-session/
CATEGORIES:Medilink Partner Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/365c5295c6f89d80b6b7d0cabc5af4f0.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201029T110000
DTEND;TZID=Europe/London:20201029T120000
DTSTAMP:20260403T200400
CREATED:20200824T083913Z
LAST-MODIFIED:20200824T083913Z
UID:18337-1603969200-1603972800@www.medilinkmidlands.com
SUMMARY:Webinar: Food Supplements Special Interest Group (SIG)- CBD and the latest developments
DESCRIPTION:Join us online for our next Food Supplements Special Interest Group (SIG) to hear about how\, within the space of a couple of years\, CBD ingestibles have transitioned from a lightly regulated consumer product to potentially being classified as a narcotic and banned from the shelves of retail outlets in Europe. How did this happen and what’s the impact on the CBD industry? \nWe invite you to hear some of the facts around CBD\, providing clarity about its current status and the future challenges and opportunities for companies operating in this sector. All of this will be presented by our speakers\, Janet Worrell\, Head of Regulatory at JensonR+ and Greer Deal\, Director of Global Regulatory Services \nAs well as the opportunity to hear some facts about CBD you can take part in a question and answer session. \nDURATION: 1 Hour \nTO BOOK YOUR PLACE PLEASE CLICK HERE\nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nJanet Worrell\, Head of Regulatory\, JensonR+ \nJanet is an experienced regulatory affairs professional\, having supported a diverse portfolio of products\, for a number of companies across the East Midlands. Janet’s experience covers early concept development\, food supplements\, over the counter (OTC) medicines\, inhaled therapies and clinical trial applications. Janet enjoys collaborating with companies to develop their regulatory strategy to deliver commercial success. Janet is an independent board member of the East Midlands Academic Health Science Network supporting innovation within NHS. \n  \nGreer Deal\, Director\, Global Regulatory Services \nGreer has over 25 years’ experience in the life science sector and 13 years ago she co-founded Global Regulatory Services with her husband\, Bobby Deal. One of their first projects involved medicinal cannabis and since then the company has become increasingly involved in plant-derived products whether medicinal\, food or cosmetics. Since January 2019\, Global Regulatory Services has become known as the leading advisers to companies in the cannabis industry with particular expertise in navigating the EU Novel Foods Regulation.
URL:https://www.medilinkmidlands.com/event/webinar-food-supplements-special-interest-group-sig-cbd-and-the-latest-developments/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Greer-Deal.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201103T110000
DTEND;TZID=Europe/London:20201103T120000
DTSTAMP:20260403T200400
CREATED:20200916T063905Z
LAST-MODIFIED:20200916T063905Z
UID:18366-1604401200-1604404800@www.medilinkmidlands.com
SUMMARY:Webinar: Medicines Management in Professional Sport
DESCRIPTION:Join Medilink East Midlands\, in partnership with MedsOnTrack and JensonR+ to discuss Medicines Management in Professional Sport. \nOur speaker\, Steve Simbler\, is a pharmacist with over 20 years’ experience working in elite sport. Steve will share some of his experiences as one of the lead pharmacists for the London 2012 Olympics and Paralympics\, as well as some of the other events with which he has been involved. He will also describe his work with elite teams in various sports\, including topics such as: \n• the volumes of analgesics and anti-inflammatories taken by players/athletes\n• storage and security issues in training grounds and also associated with travel\n• lack of full time doctors in professional sport and problems associated with other healthcare professionals administering medications to players\n• record-keeping issues\n• controlled drugs issues\n• emergency & trauma medications management in a sports environment\n• lack of regulatory oversight or independent monitoring\n• concerns over doping issues \nDURATION: 1 HOUR \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants \nSpeaker Profiles: \n \nSteve Simler MRPharm.s\, MedsOnTrack \nSteve has been working as a pharmacist in elite sport for over 20 years\, initially in a supply capacity\, and for the past 10 years in providing medicines management consultancy and software to teams in the Premier League and English Football League as well as national governing bodies for football\, rugby\, athletics\, tennis\, cricket\, rowing\, and cycling amongst others.\nHe was one of the lead pharmacists for the London 2012 Olympics and Paralympics\, then again for the London 2017 Athletics and Para-Athletics World Championships.\nAs well as giving talks about vitamin D\, he lectures on various topics pertaining to drugs in sport and the use of analgesics and anti-inflammatories in sport.\nIn 2006\, sport doctors approached Steve to advise on obtaining a reliable source of vitamin D that could pass tests for WADA-prohibited substances\, this prompted an association with Synergy Biologics\, makers of Pro D3\, and this relationship is ongoing\, and stimulated an interest in vitamin D on which he keeps abreast of research\, and reads extensively.\nSince 2016 Steve has been a pharmacist panel member for the General Pharmaceutical Council’s Fitness to Practise Committee\, and has recently started as an NHS Test and Trace clinical contact tracer on a part time basis. \n \nJanet Worrell\, Head of Regulatory\, JensonR+ \nJanet is an experienced regulatory affairs professional\, having supported a diverse portfolio of products\, for a number of companies across the East Midlands. Janet’s experience covers early concept development\, food supplements\, over the counter (OTC) medicines\, inhaled therapies and clinical trial applications. Janet enjoys collaborating with companies to develop their regulatory strategy to deliver commercial success. Janet is an independent board member of the East Midlands Academic Health Science Network supporting innovation within NHS.
URL:https://www.medilinkmidlands.com/event/webinar-medicines-management-in-professional-sport/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201104T100000
DTEND;TZID=Europe/London:20201104T123000
DTSTAMP:20260403T200400
CREATED:20201019T114917Z
LAST-MODIFIED:20201019T114917Z
UID:18392-1604484000-1604493000@www.medilinkmidlands.com
SUMMARY:Developing Better Products for Chronic Disease and Rehab Markets
DESCRIPTION:Wednesday 4th Nov 20 \nAGENDA \nThe use of clinical data\, the application of artificial intelligence and the development of digital health have been predicted to revolutionise health care and the management and rehab of chronic conditions. This event will highlight gaps in the current healthcare landscape that require new products and the funded innovation support available to engage with clinicians and the healthcare system. \nAre you developing a medical devices\, medical apps or other interventions designed to manage or prevent chronic diseases such as diabetes\, cardiovascular or respiratory disease or the long term effects of COVID-19. Hear from Clinicians at Leicester hospitals who will be identifying what new products are required to improve proactive health management. \n\n\n\n10.00\nWelcome and Overview of Leicester Biomedical Research Centre \nProfessor Tom Yates\, Professor in Physical Activity\, Sedentary Behaviour and Health\, NIHR Leicester Biomedical Research Centre\n\n\n10.20\nUsing AI and data to develop better healthcare products \nChristine Nakatani\, Ph.D. Director of Artificial Intelligence NTT DATA UK \n\n\n10.40\nStand More AT Work– preventing chronic disease in office/home based workers  \nDr Charlotte Edwardson\, Associate Professor in Physical Activity\, Sedentary Behaviour and Health\, NIHR Leicester Biomedical Research Centre     \n\n\n11.55\nCollaborating to tackle COVID-19 complications  \nYour COVID-19 recovery ground-breaking NHS online COVID-19 Rehab service Nikki Gardiner\, Clinical Lead for Cardiac & Pulmonary Rehabilitation\, University Hospitals of Leicester NHS Trust \nPost-HOSPitalisation COVID-19 study – a national consortium to understand and improve long-term health outcomes  \nDr Aarti Parmar\, PHOSP programme Manager\, NIHR Leicester Biomedical Research Centre\n\n\n11.15\nElephant Kiosks – Developing COVID-19 screening in the workplace \nProfessor Toru Suzuki\, Professor of Cardiovascular Medicine\, University of Leicester\, Honorary Consultant\, Cardiology\, University Hospitals of Leicester NHS Trust and Annette Walker Managing Director Elephant Kiosks \n\n\n11.25\nPersonalised Space Technology Exercise Platform P-STEP \nProfessor Andre Ng\, Head of Department\, Cardiovascular Sciences\, Professor of Cardiac Electrophysiology\, Consultant Cardiologist and Electrophysiologist\n\n\n11.40\nChallenge workshop – What are your challenges in developing wearables and how can the Leicester Life Sciences Accelerator help \nConference participants can ask the clinical experts or highlight problems they have experienced in the development of wearables \nDr Christopher Brough\, Clinical Lead for Digital Health\, Dr Alex Rowlands\, Diabetes Research Centre\, Dr Lucy Alexander\, LLSA Manager\n\n\n12.30\nClose\n\n\n\nBook your tickets here \nhttps://lbf2020.ticketleap.com/developing-better-products-for-chronic-disease-and-rehab-markets/
URL:https://www.medilinkmidlands.com/event/developing-better-products-for-chronic-disease-and-rehab-markets/
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201104T160000
DTEND;TZID=Europe/London:20201104T170000
DTSTAMP:20260403T200400
CREATED:20201026T095812Z
LAST-MODIFIED:20201026T095812Z
UID:18408-1604505600-1604509200@www.medilinkmidlands.com
SUMMARY:WEBINAR: Medical Devices\, Brexit and the Border
DESCRIPTION:In this Medilink Midlands webinar\, the Office for Life Sciences\, the Government’s specialist team that sponsors the sector\, will present on everything MedTech firms need to know about the end of the Transition Period\, and what will happen next. \nThis webinar will cover: \n1. The latest on Trade Negotiations with the European Union\, as well as the United States and Australia. \n2. How the regulation of MedTech is changing from the 1 January\, what your business needs to get ready\, and how the UK will develop a new sovereign system. \n3. How the border\, imports and exports will work from 1 January; and \n4. Action that firms need to take on Data\, Immigration and Global Recruitment\, and EU research funding. \n  \nThe session will include a Q&A session\, as well as guidance on where to go for further information\, support and advice. \nSpeaker Profiles \n \nAlex Mclaughlin\, Head of International Trade and Medical Device Regulation\, Office for Life Sciences \nAlex is responsible for all of OLS’s work on International Trade and Medical Device Regulation\, advising Ministers in the Business and Health Departments. \nPrior to his current role\, Alex was Senior Private Secretary to two Health Ministers\, established the Department’s epidemic vaccines programme\, and worked for the Chief Medical Officer. \n  \n  \n \n  \nJess Kirby\, Senior Policy Advisor\, International Trade and Medical Devices\, Office for Life Sciences \nJess is a trade and medical device expert\, who has worked in the Business Department for three years – with roles focussed on Brexit and International Trade. \nPrior to this\, Jess trained as an NHS Radiographer and worked in a specialist Medical Device firm. \n  \n  \n  \n 
URL:https://www.medilinkmidlands.com/event/webinar-medical-devices-brexit-and-the-border/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Alex-Mclaughlin.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201105T100000
DTEND;TZID=Europe/London:20201105T110000
DTSTAMP:20260403T200400
CREATED:20201028T084958Z
LAST-MODIFIED:20201028T084958Z
UID:18414-1604570400-1604574000@www.medilinkmidlands.com
SUMMARY:Medilink Midlands Virtual Coffee Break - members only
DESCRIPTION:An informal gathering\, hosted by Dr. Darren Clark\, Chief Executive at Medilink Midlands. \nAn opportunity to share current challenges and experiences and make introductions to those that can help. \nWe’re here to help\, so let Medilink along with the virtual group work together to help each other with any concerns\, issues\, or solution needs you may have. If you have any questions or comments\, please feel free to submit in advance to make sure we cover your needs and meet expectations. \nBOOK YOUR FREE PLACE HERE
URL:https://www.medilinkmidlands.com/event/medilink-midlands-virtual-coffee-break-members-only/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201105T140000
DTEND;TZID=Europe/London:20201105T143000
DTSTAMP:20260403T200400
CREATED:20200921T121321Z
LAST-MODIFIED:20200921T121321Z
UID:18371-1604584800-1604586600@www.medilinkmidlands.com
SUMMARY:Brexit/UKCA Marking Webinar
DESCRIPTION:SEHTA and Psephos are pleased to bring you this FREE TO ATTEND webinar on Brexit/UKCA Marking. \nThe UKCA (UK Conformity Assessed) Marking is a new UK product marking that will be used for goods being placed on the market in Great Britain (England\, Wales and Scotland).  It covers most goods which previously required the CE Marking\, including medical devices and in vitro diagnostics.  Therefore\, from 1 January 2021\, there will be a number of changes to how companies will be able to place medical devices on the market in Great Britain. \nThursday 5th November 2020 \nTime:   14:00 – 14:30  (BST) \nCost:    Free to attend \nFacilitator:   Jacques du Preez\, Director\, Psephos Biomedica \nThis webinar will be delivered via Webex.\nFrom 1 January 2021\, there will be a number of changes to how companies will be able to place medical devices on the market in Great Britain which will include: \n\nA new route to market and product marking will be available for manufacturers wishing to place a device on the Great Britain market from 1 January 2021\n\n\nFrom 1 January 2021\, all medical devices and in-vitro diagnostic medical devices (IVDs) placed on the UK market will need to be registered with the MHRA. There will be a grace period for registering – 4 months for Class IIIs and Class IIb implantables\, and all active implantable medical devices; 8 months for other Class IIb and all Class IIa devices; and 12 months for Class I devices\n\n\nCE Marking will continue to be used and recognised until 30 June 2023\n\n\nIf you are a manufacturer based outside the UK and wish to place a device on the UK market\, you will need to establish a UK Responsible Person who will take responsibility for the product in the UK. Further detail on the UK Responsible Person\n\nTarget audience:  Manufacturers based outside of the UK wanting to access the UK market\, UK based manufacturers wanting to access the EU market\, Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nPlease note that places are limited & the organisers have the right to review all applications.  \nClick here to book
URL:https://www.medilinkmidlands.com/event/brexit-ukca-marking-webinar/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201110T103000
DTEND;TZID=Europe/London:20201110T113000
DTSTAMP:20260403T200400
CREATED:20200907T094450Z
LAST-MODIFIED:20200907T094450Z
UID:18349-1605004200-1605007800@www.medilinkmidlands.com
SUMMARY:Webinar: The Value of Digital Health
DESCRIPTION:Digital Healthcare has undergone a dramatic acceleration during 2020. The requirement to deliver care remotely has accelerated adoption of new technologies\, new care pathways and new learning like never before. \nThis event is in partnership with the Digital Health Team at De Montfort University will provide an insight into the latest developments in this area\, supporting the future of healthcare. \nThis webinar will cover: \n-Examples of real-world application of digital technology in health and social care. \n-Examining the challenges and solutions to enhancing equitable access. \n-Exploring the benefits of digital health for patients\, healthcare professionals\, and society. \n-Understanding how partner organisations can demonstrate their digital health intervention delivers value. \nThis webinar is open to all organisations keen to explore and understand the digital health landscape. \nDuration: 1 hour \nThis free to attend webinar will be held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund. For further details please click here. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nThe webinar is part of the programme of events for Leicester Business Festival 2020\, De Montfort University are proud to be Headline Partner. For further details on the festival\, please click here. \nSpeaker Profiles: \n \nDr Simon Oldroyd\, Interim Deputy Vice-Chancellor \nDr Simon Oldroyd is the University’s Interim Deputy Vice-Chancellor (iDVC).  Simon is Deputy to the Interim Vice-Chancellor on all academic matters.  His responsibilities include day-to-day academic leadership of the university and strategic and operational oversight and line management of the faculty Pro Vice-Chancellor/Deans and three cross cutting Pro Vice-Chancellor portfolios. \n  \n  \n  \n \nProfessor David Mba\, Pro Vice-Chancellor (Research and Enterprise) \nProfessor David Mba was appointed Pro Vice-Chancellor and Dean of Computing\, Engineering and Media in August 2017. In May 2019\, he also took on the role of PVC (Enterprise)\, and in March 2020 he also took on the role of PVC (Research). \nDavid’s current research is focused on machine condition monitoring\, machine fault diagnosis\, model based prognostics and machine performance prediction. \n  \n  \n \nProfessor Bertha Ochieng\, Professor of Integrated Health and Social Care \nBertha Ochieng is Professor of Integrated Health and Social Care\, Faculty of Health and Life Sciences\, De Montfort University. A key aspect of her research is in examining digital solutions that support development of integrated models of health and social care and community engagement. \n  \n  \n  \n  \nProfessor Barnaby Poulton\, MRPharmS FFCI; Hon. Professor of Digital Medicine and Director Digital Health and Care Unit. Digital Health Strategist \nBarnaby is a pharmacist by training who has switched his focus to digital health.  He has built and led multiple digital health companies and co-founded the Digital Health and Care Unit at DMU to support the evaluation of novel technologies\, enabling them to enter market and deliver benefits to patients. \n 
URL:https://www.medilinkmidlands.com/event/webinar-the-value-of-digital-health/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/colour-landscape-2-scaled.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201111T133000
DTEND;TZID=Europe/London:20201111T143000
DTSTAMP:20260403T200400
CREATED:20201026T095812Z
LAST-MODIFIED:20201026T095812Z
UID:18418-1605101400-1605105000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Medicines\, Brexit and the Border
DESCRIPTION:In this Medilink Midlands webinar\, the Office for Life Sciences\, the Government’s specialist team that sponsors the sector\, will present on everything firms developing\, manufacturing and selling Medicines need to know about the end of the Transition Period\, and what will happen next. \nIn particular\, they will cover: \n– The latest on Trade Negotiations with the European Union\, as well as the United States and Australia \n– How the regulation of Medicines is changing from the 1 January\, what your business needs to get ready\, and how the UK will develop a new sovereign system \n–  How the border\, imports and exports will work from 1 January; and \n–  Action that firms need to take on Data\, Immigration and Global Recruitment\, and EU research funding \nThe session will include plenty of time for questions\, as well as guidance on where to go for further information\, support and advice. \nPlease note – this webinar will cover similar material to the webinars run by Medilink Midlands and the Office for Life Sciences on 4 and 23 November. \nDURATION: 1 hour \nSpeaker Profiles: \n\nDr Robert Reid\, Head of Medicines Regulation and Engagement\, Office for Life Sciences\nRobert works in the Office for Life Sciences\, where he is responsible for Medicines Regulation and Business Readiness for the end of the Transition Period. Rob holds a PhD in Molecular Biology from the University of Leicester\, and previously worked at the National Physical Laboratory and Which? \n\nElspeth Bailey\, Policy Advisor\, Office for Life Sciences\nElspeth works in the Office for Life Sciences\, where she leads on the Northern Ireland Protocol and supports work on Business Readiness for the end of the Transition Period. Previously\, Elspeth has taught in China\, and worked in the Government team responsible for the Aerospace Sector.
URL:https://www.medilinkmidlands.com/event/webinar-medicines-brexit-and-the-border-2/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Robert-Reid.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201112T100000
DTEND;TZID=Europe/London:20201112T104500
DTSTAMP:20260403T200400
CREATED:20201103T162843Z
LAST-MODIFIED:20201103T162843Z
UID:18423-1605175200-1605177900@www.medilinkmidlands.com
SUMMARY:WEBINAR: Microsoft 365 Tools – a smarter and more productive way to work
DESCRIPTION:Microsoft Teams has proven a vital tool to share information securely and support new ways of working during the Covid-19 pandemic. \nJoin Medilink Midlands and Tim Price\, Train IT Midlands (Microsoft Certified Trainer) on Thursday 12 November to find out how you can improve productivity and enhance collaboration across your organisation and the life sciences and healthcare community. \nThis 45-minute webinar will: \n– Benefit your organisation that requires collaboration tools to communicate with colleagues across the world and share information in real-time.\n– Highlight useful features it contains that individuals may not know\, due to little or no formal training in Office 365.\n– Improve employee and employer skill levels in the way they can work smarter\, faster from administration through to project management underpins increases in development and manufacturing. \nWhat will attendees gain from attending this event? \nThe time saving and cost benefits are significant in several areas across the business. \n– Manage and organise documents more efficiently between co-workers and reduce duplication\n– Reduce the need and cost of third party cloud file storage to share documents and online meeting software across your organisation.\n– Improve remote working capabilities\, using simple chat\, group chat\, and video conferencing.\n– Unify the way you collaborate and share information internally and with third parties. \nTO BOOK YOUR FREE PLACE CLICK HERE
URL:https://www.medilinkmidlands.com/event/webinar-microsoft-365-tools-a-smarter-and-more-productive-way-to-work/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201112T103000
DTEND;TZID=Europe/London:20201112T113000
DTSTAMP:20260403T200400
CREATED:20200921T111505Z
LAST-MODIFIED:20200921T111505Z
UID:18407-1605177000-1605180600@www.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:Join EMAHSN for a virtual coffee break on Thursday 12 November at 10:30am\, to have a chat about the digital landscape in the NHS. This informal gathering will be hosted by Mike Watson\, Digital Lead and you will have the opportunity to share your experiences and find out how the EMAHSN can help. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis still restricts face to face events\, this online opportunity enables the life sciences community to still connect with one another. \nGrab a coffee\, a biscuit and join us. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \n[popup_trigger id=”2016″ tag=”button” classes=”eventbutton”]Book Now[/popup_trigger] \n 
URL:https://www.medilinkmidlands.com/event/nov1211/
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201116
DTEND;VALUE=DATE:20201120
DTSTAMP:20260403T200400
CREATED:20200921T123156Z
LAST-MODIFIED:20200921T123156Z
UID:18374-1605484800-1605830399@www.medilinkmidlands.com
SUMMARY:Midlands Engine Market Visit to Medica 2020
DESCRIPTION:Are you a life science company looking to showcase your expertise and innovative overseas? Have you never visited the Medica Exhibition before? \nIf you can answer yes to both – then the Midlands Engine market visit to Medica 2020\, the world’s largest medical technology and life sciences exhibition\, could be your next stop. \nAbout the visit \nThe visit will give businesses the opportunity to meet and connect with international buyers and establish valuable contacts. At the exhibition\, companies will be supported by a DIT life sciences sector specialist and have access to the following facilities: \n•  Meeting 1-2-1 programme and/or virtual 121 programme with DIT sector specialists\n•  A wealth of networking opportunities\n•  Access to British Pavilion facilities including internet\, seating and light refreshments\n•  Free use of meeting facilities\n•  Companies will feature in a Midlands Engine e-brochure and the UK@Medica exhibitor directory\n•  Access to a discounted hotel rate at a hotel within walking distance of the exhibition \nYour safety \nDuring these extraordinary times\, the organisers Messe are making provision to ensure social distancing is maintained at the fair with wider aisles between stands and hygiene management on site. To protect stand staff and visitors\, entry into the British Pavilion stand will be managed\, only allowing a limited number of people on the stand at any given time. Visitors will be asked to use the hand sanitiser provided before entering the stand. Meeting tables will be sanitised between visitors. \nMidlands Engine presence and activity at Medica will be in accordance with the most up to date UK guidance as well as that of the German Government. You can also see here for information about visiting Medica. \nCosts & Funding \nThere is a non-refundable commitment fee of £99 plus VAT\, payable upon registration. Funding of £250 per company is available to eligible companies\, which is payable on return. There is a limit of 1 delegate per company and delegates will be responsible for booking flights and accommodation. \nRegister your interest today \nFor more detailed information or to register your interest in this trade visit using the link below. \nClick here to book
URL:https://www.medilinkmidlands.com/event/midlands-engine-market-visit-to-medica-2020/
LOCATION:Dusseldorf\, Germany
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201116T080000
DTEND;TZID=Europe/London:20201119T170000
DTSTAMP:20260403T200400
CREATED:20200108T151537Z
LAST-MODIFIED:20200108T151537Z
UID:18053-1605513600-1605805200@www.medilinkmidlands.com
SUMMARY:Medica 2020
DESCRIPTION:Medica is the world’s largest healthcare and life sciences exhibition\, attracting over 120\,000 global visitors annually. It has been running for over 40 years and underpins a lot of companies’ annual marketing plans. \nMedica provides an opportunity for over 6\,000 exhibiting companies (from over 60 countries) to showcase the latest healthcare technologies\, products\, equipment and services to a huge variety of global visitors. These include experts and decision-makers from across the healthcare and life sciences sector\, alongside leading individuals from business\, research\, and politics. \nMedilink UK have been involved with Medica for over 20 years and following the phenomenal success and popularity of our UK pavilion at the 2019 event\, exhibition stand space for 2020 is available for booking now. It is the perfect opportunity to network with target visitors\, increase brand exposure and generate new business and it is advised to book sooner rather than later\, as the pavilion is set for significant growth. \nWhy book with Medilink UK? \n\nExcellent location on the British pavilion with other UK companies\n• Access to preferential Medilink accommodation rate with all required transfers provided\n• Exhibition stand space on a high quality\, UK branded pavilion\n• Full spectrum exhibition support before\, during and after the event\n• Onsite assistance from our events and international trade experts\n• A range of packages to suit your exhibiting goals*\n• Hot and cold refreshments on exhibition days\n• Support with freight\, logistics and travel arrangements\n• Access to national and regional funding for eligible companies*To book your exhibition stand \, please complete here.\n\n*For further information or to discuss your requirements\, please click here to email or call: 0114 232 9292.
URL:https://www.medilinkmidlands.com/event/medica-2020/
LOCATION:Dusseldorf\, Germany
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201118T100000
DTEND;TZID=Europe/London:20201118T113000
DTSTAMP:20260403T200400
CREATED:20200325T135017Z
LAST-MODIFIED:20200325T135017Z
UID:18395-1605693600-1605699000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Medical Technologies & Systems Special Interest Group (SIG)
DESCRIPTION:The next Medical Technologies & Systems Special Interest Group (SIG) will take place online\, join us as we discuss Digital Therapeutics\, Diagnostics and Connected Devices. \nAttend to hear about:\n– Technical challenges in using wearables for depression prevention\, diagnosis\, monitoring and treatment\n– Technological approaches towards dementia diagnostics and safeguarding\n– Using machine learning to predict and diffuse meltdown events in students with autism \nDURATION: 1.5 hours \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles:  \n\nChaired by: Professor Philip Breedon\, Professor of Smart Technologies\, Nottingham Trent University \nAs well as his role at Nottingham Trent University\, Philip is also a Chartered Engineer and a Chartered IT professional. He is a member of the Department of Health’s National Institute for Health Research invention for innovation funding panel and holds a number of journal editorial positions. His research interests and latest projects centre on new and emerging technologies and materials. This includes wearable technologies\, 3D printing of pathological models\, additive and subtractive manufacturing for medical applications\, surgical robotics\, cardiovascular devices\, augmented /virtual/immersive technologies and environments\, the surgical pathway and investigative research related to the utilisation of ‘smart materials’ for medical applications. Through promoting his work and research activities he now works with a number of surgeons and clinicians across Europe. \n \nProf. David J. Brown – Professor in Interactive Systems for Social Inclusion\, Nottingham Trent University\nDavid is Professor of Interactive systems for Social Inclusion\, with the Department of Computer Science at Nottingham Trent University. Recent grants on which he has acted as PI include 2 EU H2020 projects (MaTHiSiS and No One Left Behind) on affective computing and digital game making for students with learning disabilities and autism\, an EPSRC project (An Internet of Soft Things) on co-design of networked soft textile interfaces to promote mental wellbeing\, and a range of EU Erasmus projects (e.g.\, Pathway+) to use affective computing to provide personalised learning pathways for students with learning disabilities. He is Conference Co-Chair for the International Conference of Virtual Reality\, Disability and Associated Technologies\, and Associate Editor for Frontiers – Virtual Reality and Medicine. \n\nDr John Broulidakis- Research Scientist\, Emteq Labs\nJohn was educated at the university of Sussex where he gained a first-class honours degree in Psychology with Neuroscience. John completed his PhD at the University of Southampton in Cognitive Neuroscience in 2019. He has direct experience of the issues and challenges associated with managing large and complex clinical studies having successfully managed a €2.5million EU funded study. Currently he is working as a research scientist for medical device manufacture Emteq Labs. There he is involved in manufacturing ecologically valid\, “context aware” emotion recognition systems though novel wearable devices\n \n\nProf. Michael Hornberger- (Professor of Applied Dementia Research\, Norwich Medical School\, University of East Anglia) Associate Dean of Innovation\, Faculty of Medicine and Health Sciences\, University of East Anglia)\nMichael is the Professor of Applied Dementia Research at the Norwich Medical School and the Associate Dean of Innovation\, Faculty of Medicine and Health Sciences. His research focuses on improving diagnosis\, disease progression tracking and symptom management in dementia. His research group employs various research methodologies (clinical\, cognition\, sensor technology\, neuroimaging and genetics) as well as disease interventions (pharmacological and non-pharmacological) for their research studies. His current research is particularly focused on spatial orientation and navigation deficits in dementia and how this has an impact on people’s outdoor activities such as driving and walking safely.
URL:https://www.medilinkmidlands.com/event/medical-technologies-systems-special-interest-group-sig-4-2nov/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/John-Broulidakis.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201119T103000
DTEND;TZID=Europe/London:20201119T113000
DTSTAMP:20260403T200400
CREATED:20200820T114141Z
LAST-MODIFIED:20200820T114141Z
UID:18335-1605781800-1605785400@www.medilinkmidlands.com
SUMMARY:Webinar: Is your Business Case NHS Ready?
DESCRIPTION:Registration for this event is now closed. \nJoin the second of our two-part CPD accredited virtual workshops\, Is your Business Case NHS Ready?\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nThe challenge as innovators and companies selling to the NHS is often that when you have a product that improves patient outcomes and saves cost you still cannot get it adopted by the NHS. This is frequently because there isn’t a fully developed business case. \nPART 1 is a pre-recorded 40 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– What a business case is\, what is its purpose and why is it so important? \n– Who reviews the business case and how are they evaluated? \n– How to construct a good business case \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Thursday 19th November. \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \nThis free to attend virtual event will be held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £222\, but is delivered completely free of charge to participants. \n  \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nSPEAKER PROFILE: \n \nNicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands.
URL:https://www.medilinkmidlands.com/event/webinar-is-your-business-case-nhs-ready-2/
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201123T103000
DTEND;TZID=Europe/London:20201123T113000
DTSTAMP:20260403T200400
CREATED:20201109T101547Z
LAST-MODIFIED:20201109T101547Z
UID:18426-1606127400-1606131000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Regulation\, Immigration and Research: What changes at the end of the year
DESCRIPTION:In this Medilink Midlands webinar\, the Office for Life Sciences\, the Government’s specialist team that sponsors the sector\, will present on everything Life Sciences firms need to know about the end of the Transition Period\, and what will happen next. \nIn particular\, they will cover: \n\n-The latest on Trade Negotiations with the European Union\, as well as the United States and Australia.\n-How the regulation of Medicines and Medtech is changing from the 1 January\, what your business needs to get ready\, and how the UK will develop a new sovereign system.\n-How the border\, imports and exports will work from 1 January\n-Action that firms need to take on Data\, Immigration and Global Recruitment\, and EU research funding.\n\nThe session will include plenty of time for questions\, as well as guidance on where to go for further information\, support and advice. \nPlease note – this webinar will cover similar material to the webinars run by Medilink Midlands and the Office for Life Sciences on 4 and 11 November.\nDuration: 1 hour \nTO BOOK YOUR FREE PLACE PLEASE CLICK HERE\nSpeaker Profiles \n Alex Mclaughlin\, Head of International Trade and Medical Device Regulation\, Office for Life Sciences \nAlex is responsible for all of OLS’s work on International Trade and Medical Device Regulation\, advising Ministers in the Business and Health Departments. \nPrior to his current role\, Alex was Senior Private Secretary to two Health Ministers\, established the Department’s epidemic vaccines programme\, and worked for the Chief Medical Officer. \n  \n Jess Kirby\, Senior Policy Advisor\, International Trade and Medical Devices\, Office for Life Sciences \nJess is a trade and medical device expert\, who has worked in the Business Department for three years – with roles focussed on Brexit and International Trade. \nPrior to this\, Jess trained as an NHS Radiographer and worked in a specialist Medical Device firm.
URL:https://www.medilinkmidlands.com/event/webinar-regulation-immigration-and-research-what-changes-at-the-end-of-the-year/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/jess-kirby-2.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201125T110000
DTEND;TZID=Europe/London:20201125T120000
DTSTAMP:20260403T200400
CREATED:20200902T133927Z
LAST-MODIFIED:20200902T133927Z
UID:18415-1606302000-1606305600@www.medilinkmidlands.com
SUMMARY:WEBINAR: Ensuring your Clinical Trial helps you to sell your products
DESCRIPTION:Join this webinar to hear from Afortori Development and Pym’s Consultancy\, on tips and advice for ensuring your Clinical Trial helps you to sell your products. \nThe reason for conducting trials is to validate your product or service so that you can enter the market or increase sales.  \nBefore you start planning your trial you need to establish what your long term goals are\, and then how evidence and validation will help you reach those goals. In this way your research and development strategy is embedded into your overall business strategy – in short every element of your business complements the others and your company has a clear road map for the future helping you to maximise your return on investment in all parts of the business. \nIn the sales process a successful trial starts as a talking point\, delivers evidence to support your sales pitch\, and validates your product to the wider NHS environment\, broadening your reach into the market. \nAttend to learn about the above and take the opportunity to get your questions answered by the experts. \nDURATION: 1 hour \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n\nDr Nicola Wall\, Chief Executive Officer\, Afortori Development\nNicola Wall \, along with Elizabeth Ralph founded Afortiori Development after long careers in clinical research within a variety of roles. Both bring a commitment to well designed and successfully executed clinical trials. \n\nKate Pym\, Managing Director\, Pym’s Consultancy\nKate Pym is Managing Director of Pym’s Consultancy Ltd\, an independent consultancy providing services for SMEs and universities supporting grant applications\, responses to tender and commercialisation\nKate has over 20 years’ experience of working in Health and Social Care for companies\, including Allergan Inc.\, AstraZeneca\, Mitie and Baxter Healthcare. With a focus on innovative products and services. She has worked across the NHS\, public\, private and third sectors to produce patient-centred\, high quality\, outcome based services and facilitate the market entry and growth of new products.\nKate’s experience covers: Product launches\, writing winning bids\, working with commissioners to model population outcomes\, designing\, selling and mobilization of new integrated services. She has a clear focus on outcomes and what is required to demonstrate them\, with a view to extension and expansion of constructive innovation.  Since 2014 Kate has supported over 40 organisations as managing director of Pym’s.
URL:https://www.medilinkmidlands.com/event/webinar-ensuring-your-clinical-trial-helps-you-to-sell/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Kate-pYM.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201125T160000
DTEND;TZID=Europe/London:20201125T170000
DTSTAMP:20260403T200400
CREATED:20201106T153045Z
LAST-MODIFIED:20201106T153045Z
UID:18425-1606320000-1606323600@www.medilinkmidlands.com
SUMMARY:Virtual Event: Medilink East Midlands Annual General Meeting
DESCRIPTION:The Medilink East Midlands Annual General Meeting (AGM) will take place online on Wednesday 25th November. \nThis is an opportunity to find out how Medilink East Midlands has performed over the last financial year\, hear about our current plans and the future of Medilink Midlands. \nFollowing the formal presentations there will be a chance to meet the Directors and Executive team of Medilink East Midlands in an informal atmosphere online. \nThis is the final AGM for Medilink East Midlands\, before merging with Medilink West Midlands to form a Medilink Midlands group structure. \nPlease note: Non-members are welcome to attend the AGM\, but regrettably will not be able to participate in the voting. \n  \nJoining details will provided to delegates by a member of the Medlink EM events team once the online registration form has been completed. \n 
URL:https://www.medilinkmidlands.com/event/virtual-event-medilink-east-midlands-annual-general-meeting/
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201126T110000
DTEND;TZID=Europe/London:20201126T120000
DTSTAMP:20260403T200400
CREATED:20200922T131336Z
LAST-MODIFIED:20200922T131336Z
UID:18402-1606388400-1606392000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Getting the most out of your IP budget
DESCRIPTION:Whether you are only just starting to consider intellectual property (IP) protection or already have multiple patent applications filed\, this webinar is for all cost-conscious SMEs looking to maximise the value of your IP. \nPatent attorneys from the Life Sciences and Medical Devices teams at Adamson Jones IP\, David Gwilliam and Katherine Wright will share key points of the application process with practical tips to help you manage your IP costs. \nThis one hour webinar will cover: \n– Overview of costs and key decision points throughout the patent process\n– Make the most of your IP budget at each stage of the patent process and in the overall maintenance of a patent portfolio\n-Case studies exemplifying how to make the most of an IP budget in different scenarios\n– Q&A \nDURATION: 1 hour \nSpeaker Profiles: \n\nDavid Gwilliam\, Partner – Patent Attorney\, Adamson Jones IP \nDavid obtained a Bachelor of Science degree in Biochemistry & Genetics from the University of Nottingham\, followed by a Master of Science degree in Cancer Immunotherapy from the same university. David’s research involved studies into the effect of cytokine signalling on naïve CD4+ T-cell activation.\nFollowing completion of his studies in 2007\, David worked in industry\, for MedImmune UK Ltd\, before joining AdamsonJones in July 2008. He trained with the firm and completed his qualification as both UK and European Patent Attorney in 2012. David is involved in all aspects of patent drafting and prosecution\, predominantly in the areas of biotechnology and healthcare\, and is also a key member of our Trade Marks team\, having qualified as a Chartered Trade Mark Attorney in 2014.\nDavid is a Fellow of the Chartered Institute of Patent Attorneys\, and a member of the European Patents Institute. \n\nKatherine Wright\, Associate – Patent Attorney\, Adamson Jones IP \nKatherine graduated with a 1st Class Masters degree in Chemistry from the University of York. During her time there she completed a research project into mummification practices in Ancient Yemen\, focusing on identifying substances used in the embalming process. After graduating\, Katherine spent some time as a Research Assistant within the Physics Department at the University of Birmingham where she was part of a research team developing Positron Emission Tomography for use in industry and research.\nKatherine joined AdamsonJones in April 2010\, and trained with the firm. In April 2011 Katherine was awarded the Moss Prize for the candidate achieving the highest aggregate marks in the patent Foundation Papers of the 2010 qualifying examination\, a year later she followed that success by winning the prize for the best performance in the 2011 Advanced Patent Drafting paper\, and then she won the prize for the top mark in the 2012 Advanced Patent Attorneys’ Practice paper. Katherine qualified as a UK patent attorney in April 2013 and as European Patent Attorney in 2014\, and is involved in the full range of patent filing\, prosecution and advisory work for a variety of clients\, predominantly in the fields of pharmaceuticals\, healthcare and related technologies.
URL:https://www.medilinkmidlands.com/event/gettingthemostoutofyouripbudget/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/David-Gwilliam-AJ.png
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201201T080000
DTEND;TZID=Europe/London:20201202T170000
DTSTAMP:20260403T200400
CREATED:20201119T144359Z
LAST-MODIFIED:20201119T144359Z
UID:18456-1606809600-1606928400@www.medilinkmidlands.com
SUMMARY:Virtual Global Innovation and New Technology Health Event (GIANT) 2020
DESCRIPTION:The GIANT Health Event is an unmissable\, cost-effective global\, virtual gathering for everyone “whose business in health care\, technology\, and innovation”. It’s a vibrant\, engaged global business community and the event enables and commercialises leading Healthtech innovation from around the world. Set to be bigger and better this year as the event goes virtual\, reaching out to a global community of over 177\,000 health tech innovators\, offering more direct business networking services\, and more personalised engagement opportunities. \nMedilink Members will receive a 15% discount which must be booked via this unique link here.  \nWhy not showcase your solutions\, talent and ideas? \nExplore partnerships\, business deals and meet new leads. Discover valuable new partners and make connections that matter. GIANT is the Global Innovation And New Technology event. Accelerating innovation and commercial success: Already established\, GIANT is an unmissable “innovation conference and dynamic trade exhibition”\, showcasing leading health technologies from around the world. Meet and build partnerships with companies ranging from startups to global large corporates and get exposure to leading industry press and media and being interviewed by professional film companies. \nTo find out more please contact GIANT organiser David Wortley\, click here to email. \nIf you have any Medilink discount queries please contact Zoe Heather\, Events & Marketing Communications Manager\, click here to email Zoe.
URL:https://www.medilinkmidlands.com/event/virtual-global-innovation-and-new-technology-health-event-giant-2020/
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201201T110000
DTEND;TZID=Europe/London:20201201T120000
DTSTAMP:20260403T200400
CREATED:20200921T104423Z
LAST-MODIFIED:20200921T104423Z
UID:18367-1606820400-1606824000@www.medilinkmidlands.com
SUMMARY:CANCELLED Webinar: GDPR implications for international personal data transfers
DESCRIPTION:[box type=”shadow” align=”” class=”” width=””]We have unfortunately had to cancel this webinar due to circumstances beyond our control. We sincerely apologise for this inconvenience.  [/box] \nEarlier this year\, the European Court of Justice struck down the US Privacy Shield\, and although it focused on EU-US data transfers\, the ruling has caused widespread aftershocks for international personal data transfers within the EEA. International group companies using personal data\, or even non-international organisations which are using Cloud or other service providers in non-EEA countries (such as India or elsewhere)\, need to be aware of the implications arising from the ruling. \nFor life sciences businesses\, the kinds of data that may be affected could be data about individual patients and their treatment\, clinical trial data and information about staff\, research colleagues and physicians. Organisations have become so used to working digitally that they may not even fully appreciate when international data transfers are taking place. \nJagvinder Singh Kang\, International and UK Head of IT Law (CIPP/E\, CIPM) at Mills & Reeve considers what steps you can take to protect your organisation following the ruling. \nThis webinar will be relevant to all organisations involved in international personal data transfers from within the EEA\, whether to group companies\, service providers or other organisations. \nThere will also be an opportunity to ask the presenters questions\, when Jagvinder will be joined for a Q&A session by specialist Life Sciences Lawyer\, Stephanie Caird. \nDURATION: 1 hour \nPlease note that due to privacy restrictions this webinar will NOT be recorded and the presentation slides will not be available to download. \nThis free to attend webinar will be held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund. For further details please click here. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSPEAKER PROFILES: \n Jagvinder Singh Kang – International and UK Head of IT (CIPP/E\, CIPM) \nJagvinder is a market leading technology lawyer. He is featured in Legal 500’s official ‘Hall of Fame’ – which Legal 500 confirms: “highlights\, to clients\, the law firm partners who are at the pinnacle of the profession.” He has been recognised for 9 consecutive years in Legal 500’s ‘Elite List of Outstanding Technology Lawyers Nationwide’\, and consistently been ranked number one for IT and technology law by Legal 500 and Chambers & Partners for the same period. Jagvinder is a specialist technology and GDPR/data protection lawyer (CIPP/E\, CIPM)\, as well as a qualified software engineer (First Class BSc (Hons) Computer Science & Software Engineering) and he has completed the academic requirements for Chartered Engineer status as well. Furthermore\, he has over 20 years of technology law expertise from having advised on billions of pounds worth of UK and international technology transactions\, involving FTSE 100\, NASDAQ listed and other world-class corporates. He has also undertaken global\, European and UK GDPR compliance projects. \n  \n \nStephanie Caird – Commercial Lawyer \nStephanie is a lawyer in the life sciences practice\, with significant experience in data protection\, intellectual property\, commercial contracting and regulatory work. She supports a wide range of clients in the pharma and biotech\, medical devices and diagnostic sectors. Stephanie has worked in-house in various life sciences organisations\, giving her a unique insight into her clients. She uses this experience to deliver pragmatic and commercial advice. A key focus of her work is supporting clients on strategic decisions influenced by the regulatory framework and contracts covering IP\, research collaborations and Brexit related intra-group arrangements. \n 
URL:https://www.medilinkmidlands.com/event/webinar-gdpr-implications-for-international-personal-data-transfers/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201201T110000
DTEND;TZID=Europe/London:20201201T120000
DTSTAMP:20260403T200400
CREATED:20201007T131912Z
LAST-MODIFIED:20201007T131912Z
UID:18384-1606820400-1606824000@www.medilinkmidlands.com
SUMMARY:WEBINAR: The Medicines and Medical Devices Bill - the UK regulatory environment following Brexit
DESCRIPTION:Join Mills & Reeve for this webinar where we will discuss the Medicines and Medical Devices Bill – the UK regulatory environment following Brexit. \nAs the end of the Brexit transition period approaches we see UK Government making plans to move forward as a standalone regulatory system. A central plank of these plans is the Medicines and Medical Devices Bill. This was published in February\, and is making its way through the Parliamentary process. Although existing EU law will be brought over into the UK system from 1 January 2021\, the Bill gives broad powers to the Health Minister to develop the law to fit UK priorities. Promoting fast-track approval of innovative medicines and technologies and reducing red tape\, as well as promoting UK-based industry\, will take on greater importance. \nFor medical devices\, the situation is made more complex by the forthcoming full implementation of the new EU regulations on medical devices and in vitro diagnostics. Likewise\, the EU clinical trials system is yet to be rolled out pending completion of the EMA’s new portal and database. The UK will have to decide how closely to track these systems\, while\, of course\, adopting its own administrative structures to implement them. \nDuring this webinar we will review the latest position\, and consider likely outcomes for the UK regulatory environment. \nThere will also be an opportunity to ask the presenters questions. \nDURATION: 1 hour \nThis free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nJames Fry\, Head of Life Sciences and Partner at Mills & Reeve \nJames heads the firm’s fast growing\, multi-disciplinary life sciences practice and focuses exclusively on this sector. The practice supports clients in the pharma and biotech\, medical device\, diagnostic\, medtech and digital health sub-sectors. James’ own practice focuses on intellectual property\, commercial contracting and regulatory work. \n  \n  \n  \n \nIsabel Teare\, Senior Legal Adviser at Mills & Reeve \nIsabel Teare is a Senior Legal Adviser at Mills & Reeve. She started her career in molecular biology\, and focuses on all aspects of life sciences law and regulation. \n  \n  \n  \n  \n 
URL:https://www.medilinkmidlands.com/event/webinar-the-medicines-and-medical-devices-bill-the-uk-regulatory-environment-following-brexit/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/isabel-teare.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201202T110000
DTEND;TZID=Europe/London:20201202T120000
DTSTAMP:20260403T200400
CREATED:20201013T070828Z
LAST-MODIFIED:20201013T070828Z
UID:18388-1606906800-1606910400@www.medilinkmidlands.com
SUMMARY:WEBINAR: How to plan and deliver a successful marketing campaign - for Life Sciences companies
DESCRIPTION:Join this webinar in partnership with Robin Bodicoat\, Marketing Director at Quotient Sciences\, to learn how to plan and deliver a successful marketing campaign. \nA successful marketing campaign will deliver the right message\, to the right audience through the right marketing channels. If you under-deliver in any of these areas your marketing will fail. This webinar will explore all 3 key elements that make up a campaign:\n• Target audience\n• Message\n• Media channel \nUsing practical industry focused examples you will learn how to identify and connect with your ideal target audience\, how to develop appropriate messaging that sets you apart from your competitors and what channels you need to use to get in front of your audience. \nThis webinar is suitable for anyone working in medical\, health\, medical technologies\, pharmaceutical or scientific sectors; who are responsible for promoting your products and services. \nThere will be an opportunity to ask any questions in a Q&A session following the presentation. \nSpeaker Profile \n Robin Bodicoat\, Marketing Director at Quotient Sciences \nRobin is the CIM qualified\, Marketing Director at Quotient Sciences\, a leading drug development services organization. He is also an active Board Member of the BMC (Business Marketing Club)\, which is the independent voice of the B2B marketing industry. He has 15+ years’ experience in Life Sciences\, Pharma and Healthcare\, with knowledge in marketing campaign planning and strategy\, and brand development. In 2017 he managed the global re-brand of Quotient Sciences.
URL:https://www.medilinkmidlands.com/event/webinar-how-to-plan-and-deliver-a-successful-marketing-campaign-for-life-sciences-companies/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Robin-Bodicoat.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201208T150000
DTEND;TZID=Europe/London:20201208T163000
DTSTAMP:20260403T200400
CREATED:20201124T113532Z
LAST-MODIFIED:20201124T113532Z
UID:18463-1607439600-1607445000@www.medilinkmidlands.com
SUMMARY:VIRTUAL EVENT: Medilink Midlands Annual General Meeting (AGM)
DESCRIPTION:The Medilink Midlands Annual General Meeting (AGM) will take place online on Tuesday 8 December. \nThis AGM brings together our Midlands membership\, which we have been working towards for some time. \nFollowing the formal presentations\, you will have the chance to meet and network with fellow members and representatives from the newly appointed Board of Directors. \nYou will also hear from two of our members sharing their recent experiences and how they have benefited from their membership. \nWe’re looking forward to welcoming our members to help launch Medilink Midlands and hope you can join us\, as we open the door to new networks\, business communities\, and opportunities across the Midlands. \nCLICK HERE TO SECURE YOUR PLACE\nPlease note: Non-members are welcome to attend the AGM. \nJoining details will be provided to delegates by a member of the Medlink Midlands events team once the online registration form has been completed.
URL:https://www.medilinkmidlands.com/event/virtual-event-medilink-midlands-annual-general-meeting-agm/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201209T110000
DTEND;TZID=Europe/London:20201209T120000
DTSTAMP:20260403T200400
CREATED:20201026T114838Z
LAST-MODIFIED:20201026T114838Z
UID:18413-1607511600-1607515200@www.medilinkmidlands.com
SUMMARY:WEBINAR: Medtech Regulatory Special Interest Group (SIG) - Keeping Up With The Ever Changing Regulations
DESCRIPTION:The next Medtech Regulatory Special Interest Group (SIG) will take place online. Join us as we remove the confusion from the ever changing regulations including MDD\, IVDD\, AIMDD\, MDR\, IVDR\, UKCA & MRA\, and what it means to us in the UK. \nThe topics being discussed are:\n– Really Brief history of the Directives and their resurrected future: MDD\, IVDD\, AIMDD\n– The new MDR – current time line (less than 6 months to go)\n– The new IVDR – growing calls for a delay\n– The new UKCA Mark – for GB only!\n– What regulation applies to me?\n– Finding a Notified Body/ UK Approved Body \nThere will also be an opportunity to ask the presenter questions in a Q&A session. \nThis free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \n  \nSpeaker Profile \nPeter Rose\, Managing Director\, PRQR Ltd \nPeter is the founder of PRQR Ltd. With 26 years of experience with Medical Devices and IVDs\, Peter has expertise covering Quality Assurance\, Regulatory Affairs\, Sterilisation\, Cleanrooms and Contamination Control. He is a Microbiologist\, Chartered biologist\, Member of the RSB\, Practitioner Member of the CQI and a Member of TOPRA. \n  \n  \n 
URL:https://www.medilinkmidlands.com/event/medtech-regulatory-special-interest-group-sig-keeping-up-with-the-ever-changing-regulations/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201215T100000
DTEND;TZID=Europe/London:20201215T110000
DTSTAMP:20260403T200400
CREATED:20201112T155710Z
LAST-MODIFIED:20201112T155710Z
UID:18435-1608026400-1608030000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Planning & Executing a post Covid-19 Business Recovery Plan
DESCRIPTION:Join this Medilink Midlands webinar in partnership with Christopher Demetriou\, Head of Business Advisory at Archimedia Accounts\, to learn how to Facilitate a Business Recovery Planning Session with your team\, focused on Recovering your business impacted through Covid. \nEvery business has been impacted to some extent by the Covid-19 pandemic. We want to ensure businesses recover from the pandemic as strongly as possible.\n• Do you want certainty about your new minimum weekly viable sales level to survive?\n• Do you want to learn how to further maximise opportunities and minimise vulnerabilities and risks?\n• Would you like to reduce the cashflow strain on your business?\n• Do you want clarity on the support and finance needed for your business at this challenging time? \nA Business Recovery Planning session requires you to reconsider all aspects of your business to ensure its best chance of recovery. Archimedia Accounts work with clients to develop a concise Business Recovery Plans and clarify the future direction of their business. \nWe’ll also show you how to revise your personal and business’s budget\, maximise support entitlements\, set goals for each department\, apply for bank finance (if needed) and ensure you feel supported throughout this recovery period. \nThis webinar will show you the exact Business Recovery Planning process we undertake with clients so you can do it yourself with your team. \nThere will be an opportunity to ask your questions directly to our speaker during a Q&A session. \nSpeaker Profile \nChristopher Demetriou\, Head of Business Advisory\, Archimedia Accounts \nChris has been delivering Business Plans over the last 8 years with many of Archimedia’s clients and in that time he has lead a number of those clients towards business success. His passion is continuously understanding business strategy & culture\, and helping our clients achieve their goals.
URL:https://www.medilinkmidlands.com/event/webinar-planning-executing-a-post-covid-19-business-recovery-plan/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Chris-Demetriou.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201217T103000
DTEND;TZID=Europe/London:20201217T113000
DTSTAMP:20260403T200400
CREATED:20201123T124317Z
LAST-MODIFIED:20201123T124317Z
UID:18457-1608201000-1608204600@www.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:Join the East Midlands Academic Health Science Network (EMAHSN) for a virtual coffee break on Thursday 17 December at 10:30am\, to have a chat about the complexity of health data and where to find publicly available data to support innovation in the NHS. \nThis informal gathering will be hosted by Glen Howard\, Programme Manager – Health Analytics and Informatics and you will have the opportunity to share your experiences and find out how the EMAHSN can help. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis still restricts face to face events\, this online opportunity enables the life sciences community to still connect with one another. \nGrab a coffee\, a biscuit and join us. \nJoining details will be provided to delegates by a member of the Medilink Midlands events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \nChair: \n \n  \nGlen Howard\, Programme Manager – Health Analytics and Informatics \n  \n  \n 
URL:https://www.medilinkmidlands.com/event/east-midlands-academic-health-science-network-virtual-coffee-break-4/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Glen-Howard-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201225T080000
DTEND;TZID=Europe/London:20201225T170000
DTSTAMP:20260403T200400
CREATED:20201104T102650Z
LAST-MODIFIED:20201104T102650Z
UID:18424-1608883200-1608915600@www.medilinkmidlands.com
SUMMARY:Test Event Only
DESCRIPTION:test data \nERDF Event:\n[popup_trigger id=”1980″ tag=”button” classes=”eventbutton”]Book Now[/popup_trigger] \nNon ERDF Event:\n[popup_trigger id=”11059″ tag=”button” classes=”eventbutton”]Book Now[/popup_trigger] \nAHSN Event:\n[popup_trigger id=”6497″ tag=”button” classes=”eventbutton”]Book Now[/popup_trigger]
URL:https://www.medilinkmidlands.com/event/test-event-only/
CATEGORIES:Medilink Midlands Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210112T103000
DTEND;TZID=Europe/London:20210112T113000
DTSTAMP:20260403T200400
CREATED:20201118T180546Z
LAST-MODIFIED:20201118T180546Z
UID:18438-1610447400-1610451000@www.medilinkmidlands.com
SUMMARY:Virtual Workshop: Introduction to NHS Market Access
DESCRIPTION:Join our two-part CPD accredited virtual workshop\, Introduction to NHS Market Access\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nCombined\, the two sessions will give innovators key insights into the complexities of the NHS and wider healthcare ecosystem as well as the support available to help you to introduce your health technology product or service into the NHS. \nPART 1 is a pre-recorded 45 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– The NHS Structure \n– Understanding pathways and cash flow \n– Getting your message right \n– What support you can expect from the AHSN \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Tuesday 12th January . \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nBOOKING IS NOW CLOSED FOR THIS SESSION\n  \nSPEAKER PROFILE:  \nLive Q&A Chair:\n \n  \nTim Robinson\, Commercial Director\, East Midlands Academic Health Science Network \n  \n  \n  \n  \n \n  \nAisha Ajij\, Project Support & Industry Liaison Officer\, East Midlands Academic Health Science Network \n  \n  \n  \nJulian Patel\, Commercial Manager\, East Midlands Academic Health Science Network \n  \n\nPre-recorded Webinar:\nNicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands
URL:https://www.medilinkmidlands.com/event/virtual-workshop-introduction-to-nhs-market-access/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Tim-Robinson.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210113T140000
DTEND;TZID=Europe/London:20210113T150000
DTSTAMP:20260403T200400
CREATED:20201119T141544Z
LAST-MODIFIED:20201119T141544Z
UID:18447-1610546400-1610550000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Mental Health in the Workplace
DESCRIPTION:This Medilink Midlands webinar will explore the impact of mental health on the workplace and introduce the Mental Health and Productivity Pilot (MHPP) being offered to businesses across the Midlands Engine Region. \nA healthy and inclusive workplace is essential for all businesses so providing appropriate support for employees\, creating a culture of openness and tackling discrimination and stigma will help to remove some of the barriers to growth and development for businesses. The cost to the economy of mental health across the Midlands is estimated to be in the region of £45 billion in 2020. This will be impacted further by the covid-19 pandemic\, which no one was prepared for. \nDURATION: 1 hour \nSpeaker Profiles:\n\nDr Paula Holt – Pro Vice Chancellor and Dean of College of Health\, Psychology and Social Care\nPaula started her career as a General nurse\, specialising in acute medicine. She then became a mental health nurse working in acute psychiatry and care of older people with mental illness. She served as an Army officer for 8 years serving in SE England\, Germany and Scotland heading up mental health services for Forces personnel and their families\, and served on operational tours of Bosnia in 1993/4 with the UN and 1997 with NATO. She returned to the NHS and headed up a drug and alcohol team\, a mentally disordered offender service and developed court-mandated drug treatment for offenders. She has worked in Higher education since 2002 and is currently Pro Vice Chancellor and Dean of College of Health\, Psychology and Social Care at the University of Derby. \n \nProfessor Dean Fathers\, Chair and Non-Executive Board Member\, Mentor and Consultant\nDean has a wealth of experience in a range of organisations\, from FTSE/blue-chips in the private sector\, large national Government Departments and Public Agencies\, including over 20 years experience as the Chair of a variety of NHS organisations\, to medium sized private\, entrepreneurial companies. He is an accomplished Director\, having held numerous executive and non executive board positions and also has international experience as an organisational change leader\, practicing as a Board/Executive Development Consultant in fields as diverse as; the automotive industry\, construction\, distribution\, education\, media\, retail\, and pharmaceutical/health sectors in Europe\, North America and Asia Pacific. The development of strategy as a driver for change and sustainable long term success is his forte and this is linked to a deep understanding of best practices principles of board governance which he has honed through a number of visiting professor roles at Cass\, Leeds\, Lincoln and Nottingham Business Schools. Amongst his portfolio of roles Dean Chairs the Centre for Organisational Resilience at Lincoln International Business School which is exploring the relationship between governance and mental health. \n\nKate Wood – Project Manager Mental Health and Productivity Pilot\nKate has worked in the University’s Research and Knowledge Exchange Office for over 12 months. She brings with her over 20 years experience in business development and management\, specialising in substance misuse and mental health-having worked in the Prison Service for 10 years and across a variety of community mental health services for both vulnerable adults and young people. Her drive for positive mental wellbeing within all sectors is at the heart of her role and she feels honoured to be leading on the Mental Health and Productivity Pilot. \n\nRobin Pepper – Knowledge Exchange Manager\nRobin has some 30 years experience in a Business Development role spent primarily in the Healthcare Sector. Originally from a Communications and Marketing background\, Robin’s latter career pathway has been established within Higher Education and Health & Social Care\, in a Knowledge Exchange capacity. Much of this time has centred on working with academic partners and practitioners on the development of the workforce\, research and innovation in healthcare practice.\nWorking with employers and healthcare professionals on improving public health and reducing health inequality\, particularly with regards to community & mental health\, is a key focus of Robin’s current role at the University of Derby.
URL:https://www.medilinkmidlands.com/event/webinar-mental-health-in-the-workplace/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Paula-Holt.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR